Cargando…
Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists’ impact. Resear...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937620/ https://www.ncbi.nlm.nih.gov/pubmed/35239471 http://dx.doi.org/10.5888/pcd19.210280 |
_version_ | 1784672383024496640 |
---|---|
author | Dwyer, Gregory Popoola, Adebola Seiler, Naomi Therrien, Nicole Karacuschansky, Aaron Fulmer, Erika Horton, Katie |
author_facet | Dwyer, Gregory Popoola, Adebola Seiler, Naomi Therrien, Nicole Karacuschansky, Aaron Fulmer, Erika Horton, Katie |
author_sort | Dwyer, Gregory |
collection | PubMed |
description | Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists’ impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists’ value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists’ impact in chronic disease prevention and management. |
format | Online Article Text |
id | pubmed-8937620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-89376202022-03-31 Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic Dwyer, Gregory Popoola, Adebola Seiler, Naomi Therrien, Nicole Karacuschansky, Aaron Fulmer, Erika Horton, Katie Prev Chronic Dis Research Brief Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists’ impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists’ value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists’ impact in chronic disease prevention and management. Centers for Disease Control and Prevention 2022-03-03 /pmc/articles/PMC8937620/ /pubmed/35239471 http://dx.doi.org/10.5888/pcd19.210280 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Brief Dwyer, Gregory Popoola, Adebola Seiler, Naomi Therrien, Nicole Karacuschansky, Aaron Fulmer, Erika Horton, Katie Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic |
title | Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic |
title_full | Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic |
title_fullStr | Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic |
title_full_unstemmed | Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic |
title_short | Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic |
title_sort | chronic disease management service opportunities for community pharmacists during the covid-19 pandemic |
topic | Research Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937620/ https://www.ncbi.nlm.nih.gov/pubmed/35239471 http://dx.doi.org/10.5888/pcd19.210280 |
work_keys_str_mv | AT dwyergregory chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic AT popoolaadebola chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic AT seilernaomi chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic AT therriennicole chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic AT karacuschanskyaaron chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic AT fulmererika chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic AT hortonkatie chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic |